Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Daniel J. George, MD
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Laura Cappelli, MD, MHS,MS
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Ihtisham Ahmad
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Strategic Sequencing in Steroid-Refractory Chronic GVHD: Adapting to a New Landscape
Jennifer Caudle, DO
Doris M. Ponce, MD, MS
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Paolo Tarantino, MD
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Advances in Chronic GVHD Care: Insights from the AGAVE-201 Trial
Robert Walker, PharmD
HER2 Testing: The Evolving Role of Immunohistochemistry (IHC)
Fernando López-Ríos, MD, PhD
Christian Rolfo, MD, PhD
Charlie Gourley, MD, PhD
Targeting CD123 in AML: The Latest Therapeutic Advancements
Naval Daver, MD
Prostate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
Mohit Khera, M.D., M.B.A., M.P.H.
Slowing Prostate Cancer Progression: The Role of Dietary Fat Modifications
William Aronson, MD
From Diagnosis to Treatment: Challenges in Glioblastoma Care
Lauren Schaff, MD
Proactive Adverse Effect Management in mCRC: Improving Tolerability to Optimize Patient Outcomes
Fortunato Ciardiello, MD, PhD
Jenny Seligmann, MBChB, PhD
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.